Association of 30-second chair stand test performance with exercise intolerance and hospitalization for symptomatic heart failure in type 2 diabetes and stage B heart failure

IF 3.5 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Journal of cardiology Pub Date : 2026-10-01 Epub Date: 2026-07-06 DOI:10.1016/j.jjcc.2026.07.003
Yousuke Sugita PhD, Ayano Kudo (BSc), Sota Arakawa BSc, Satoshi Sakai MD, PhD
{"title":"Association of 30-second chair stand test performance with exercise intolerance and hospitalization for symptomatic heart failure in type 2 diabetes and stage B heart failure","authors":"Yousuke Sugita PhD,&nbsp;Ayano Kudo (BSc),&nbsp;Sota Arakawa BSc,&nbsp;Satoshi Sakai MD, PhD","doi":"10.1016/j.jjcc.2026.07.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Exercise intolerance (EI) predicts hospitalization for symptomatic heart failure (HF) in patients with type 2 diabetes mellitus (T2DM); however, cardiopulmonary exercise testing (CPET) is not always feasible in routine practice. The prognostic value of the 30-second chair stand test (CS30), a simple functional assessment correlated with peak oxygen uptake (peakVO<sub>2</sub>), remains unclear. We investigated whether the CS30 reflects exercise capacity and predicts hospitalization for symptomatic HF in patients with T2DM and stage B HF.</div></div><div><h3>Methods</h3><div>A total of 502 outpatients with T2DM and stage B HF were prospectively enrolled. Exercise capacity was assessed using peakVO<sub>2</sub> from CPET and functional performance using CS30. EI was defined as peakVO<sub>2</sub> ≤80% predicted, and abnormal-CS30 as &lt;18 repetitions for males and &lt;16 for females. Participants were followed for the first hospitalization for symptomatic HF. Associations were assessed using multivariable Cox models, and discrimination using the 5-year time-dependent area under the receiver operating characteristic curve (AUC).</div></div><div><h3>Results</h3><div>The CS30 performance was significantly associated with peakVO<sub>2</sub>. Over a median follow-up of 5.1 years, 91 patients were hospitalized for symptomatic HF. Abnormal-CS30 independently predicted hospitalization for symptomatic HF after adjustment for the WATCH-DM score, B-type natriuretic peptide, left ventricular hypertrophy, and atrial fibrillation. Adding the CS30 to resting risk models significantly improved the 5-year AUC, with performance comparable to that of EI.</div></div><div><h3>Conclusions</h3><div>In patients with T2DM and stage B HF, the CS30 reflected reduced exercise capacity and independently predicted hospitalization for symptomatic HF. Given its simplicity and feasibility, the CS30 may serve as a practical functional marker to complement resting risk models when CPET is unavailable.</div></div>","PeriodicalId":15223,"journal":{"name":"Journal of cardiology","volume":"88 4","pages":"Pages 321-328"},"PeriodicalIF":3.5000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cardiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S091450872600136X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/6 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Exercise intolerance (EI) predicts hospitalization for symptomatic heart failure (HF) in patients with type 2 diabetes mellitus (T2DM); however, cardiopulmonary exercise testing (CPET) is not always feasible in routine practice. The prognostic value of the 30-second chair stand test (CS30), a simple functional assessment correlated with peak oxygen uptake (peakVO2), remains unclear. We investigated whether the CS30 reflects exercise capacity and predicts hospitalization for symptomatic HF in patients with T2DM and stage B HF.

Methods

A total of 502 outpatients with T2DM and stage B HF were prospectively enrolled. Exercise capacity was assessed using peakVO2 from CPET and functional performance using CS30. EI was defined as peakVO2 ≤80% predicted, and abnormal-CS30 as <18 repetitions for males and <16 for females. Participants were followed for the first hospitalization for symptomatic HF. Associations were assessed using multivariable Cox models, and discrimination using the 5-year time-dependent area under the receiver operating characteristic curve (AUC).

Results

The CS30 performance was significantly associated with peakVO2. Over a median follow-up of 5.1 years, 91 patients were hospitalized for symptomatic HF. Abnormal-CS30 independently predicted hospitalization for symptomatic HF after adjustment for the WATCH-DM score, B-type natriuretic peptide, left ventricular hypertrophy, and atrial fibrillation. Adding the CS30 to resting risk models significantly improved the 5-year AUC, with performance comparable to that of EI.

Conclusions

In patients with T2DM and stage B HF, the CS30 reflected reduced exercise capacity and independently predicted hospitalization for symptomatic HF. Given its simplicity and feasibility, the CS30 may serve as a practical functional marker to complement resting risk models when CPET is unavailable.
30-s椅子站立测试表现与运动不耐受和2型糖尿病和B期心力衰竭症状性心力衰竭住院的关系
背景:运动不耐受(EI)预测2型糖尿病(T2DM)患者症状性心力衰竭(HF)住院;然而,心肺运动试验(CPET)在常规实践中并不总是可行的。30-s椅子站立测试(CS30)是一种简单的与峰值摄氧量(峰值vo2)相关的功能评估,其预后价值尚不清楚。我们研究了CS30是否反映运动能力,并预测T2DM和B期HF患者的症状性HF住院。方法:前瞻性纳入502例T2DM合并B期HF的门诊患者。用CPET测得的峰值vo2评估运动能力,用CS30评估功能表现。EI定义为峰值vo2 ≤ 预测值的80%,异常-CS30为结果:CS30表现与峰值vo2显著相关。在中位随访5.1 年期间,91名患者因症状性心衰住院。在调整WATCH-DM评分、b型利钠肽、左室肥厚和房颤后,异常cs30独立预测症状性HF住院。将CS30添加到静息风险模型中显著提高了5年AUC,其性能与EI相当。结论:在T2DM和B期HF患者中,CS30反映了运动能力的降低,并独立预测了症状性HF的住院。鉴于它的简单性和可行性,CS30可以作为一个实用的功能标记物,在CPET不可用的情况下补充静止风险模型。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of cardiology
Journal of cardiology CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
4.90
自引率
8.00%
发文量
202
审稿时长
29 days
期刊介绍: The official journal of the Japanese College of Cardiology is an international, English language, peer-reviewed journal publishing the latest findings in cardiovascular medicine. Journal of Cardiology (JC) aims to publish the highest-quality material covering original basic and clinical research on all aspects of cardiovascular disease. Topics covered include ischemic heart disease, cardiomyopathy, valvular heart disease, vascular disease, hypertension, arrhythmia, congenital heart disease, pharmacological and non-pharmacological treatment, new diagnostic techniques, and cardiovascular imaging. JC also publishes a selection of review articles, clinical trials, short communications, and important messages and letters to the editor.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书